|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C12N 15/113 | (2010.01) |
| A61K 31/712 | (2006.01) | ||
| A61K 31/7125 | (2006.01) | ||
| A61K 47/50 | (2017.01) | ||
| C07H 21/00 | (2006.01) | ||
| A61P 37/04 | (2006.01) | ||
| A61P 33/02 | (2006.01) | ||
| A61P 31/00 | (2006.01) |
| (11) | Number of the document | 3430141 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17710874.3 |
| Date of filing the European patent application | 2017-03-14 | |
| (97) | Date of publication of the European application | 2019-01-23 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (86) | Number | PCT/EP2017/055925 |
| Date | 2017-03-14 |
| (87) | Number | WO 2017/157899 |
| Date | 2017-09-21 |
| (30) | Number | Date | Country code |
| 16160149 | 2016-03-14 | EP |
| (72) |
PEDERSEN, Lykke, DK
JAVANBAKHT, Hassan, CH
JACKEROTT, Malene, DK
OTTOSEN, Soren, DK
LUANGSAY, Souphalone, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Oligonukleotidai, skirti PD-L1 raiškai sumažinti |
| OLIGONUCLEOTIDES FOR REDUCTION OF PD-L1 EXPRESSION |
| Payment date | Validity (years) | Amount | |
| 2024-02-20 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2025-03-14 |